Chronic Low-Level IFN-γ Expression Disrupts Mitochondrial Complex I Activity in Renal Macrophages: An Early Mechanistic Driver of Lupus Nephritis Pathogenesis
International Journal of Molecular Sciences · 25.12.2024 · 26 (1) · 63
DOI: 10.3390/ijms26010063 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.12.2024. Verfasst von Heekyong R Bae und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Lupus Nephritis, Macrophages, Interferon-gamma, Kidney. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Cancer Institute, CCR.
Abstract (Originalsprache)
Mitochondrial dysfunction and macrophage dysregulation are well recognized as significant contributors to the pathogenesis of autoimmune diseases. However, the detailed mechanisms connecting these two factors remain poorly understood. This study hypothesizes that low but chronic interferon-gamma (IFN-γ) plays a critical role in these processes. To explore this, we utilized ARE-Del mice, a model characterized by sustained low-level IFN-γ expression and lupus nephritis (LN)-like symptoms. Age- and tissue-dependent gene expression analyses in ARE-Del mice revealed significant suppression of mitochondrial complex I components and activities, particularly in the kidneys. The genotype-dependent suppression of mitochondrial complex I indicates early disruption, which leads to macrophage dysfunction. Notably, remission restored gene expression of mitochondrial complex I and macrophage dysfunction in isolated renal macrophages from NZB/W lupus-prone mice. These findings suggest that chronic low-level IFN-γ disrupts mitochondrial complex I activity in macrophages, highlighting its role in the early pathogenesis of autoimmune diseases like lupus nephritis. This provides new insights into the molecular interactions underlying autoimmune pathogenesis and suggests potential targets for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Nutrition, Kyungpook National University, Daegu 41566, Republic of Korea.
- Center for Food and Nutritional Genomics, Kyungpook National University, Daegu 41566, Republic of Korea.
- Omixplus, LLC., Gaithersburg, MA 20850, USA.
- Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MA 21702, USA.
- Center for Beautiful Aging, Kyungpook National University, Daegu 41566, Republic of Korea.
ORCID-Profile: Heekyong R Bae, Su-Kyung Shin, Yeo Jin Ko, Suntae Kim, Howard A Young
Förderung
- National Research Foundation of Korea
- National Cancer Institute
- CCR
- CIL
Zitieren
APA
Bae, H. R., Shin, S. K., Lee, J. Y., Ko, Y. J., Kim, S., Young, H. A., & Kwon, E. Y. (2024). Chronic Low-Level IFN-γ Expression Disrupts Mitochondrial Complex I Activity in Renal Macrophages: An Early Mechanistic Driver of Lupus Nephritis Pathogenesis. International Journal of Molecular Sciences, 26(1), 63. https://doi.org/10.3390/ijms26010063
Vancouver
Bae HR, Shin SK, Lee JY, Ko YJ, Kim S, Young HA, et al. Chronic Low-Level IFN-γ Expression Disrupts Mitochondrial Complex I Activity in Renal Macrophages: An Early Mechanistic Driver of Lupus Nephritis Pathogenesis. International Journal of Molecular Sciences. 2024;26(1):63. doi:10.3390/ijms26010063
BibTeX
@article{Bae2024,
author = {Bae, Heekyong R and Shin, Su-Kyung and Lee, Ji-Yoon and Ko, Yeo Jin and Kim, Suntae and Young, Howard A and Kwon, Eun-Young},
title = {Chronic Low-Level IFN-γ Expression Disrupts Mitochondrial Complex I Activity in Renal Macrophages: An Early Mechanistic Driver of Lupus Nephritis Pathogenesis},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {26},
number = {1},
pages = {63},
doi = {10.3390/ijms26010063}
}
EUVIMED